Vascular Birthmark Latest Advances

Journal: Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI)

Published: November 15, 2025

Clinical characteristics, treatment outcomes and prognostic factors of ulcerated infantile hemangioma: 15 years of experience from a pediatric dermatology center in Hong Kong.

Journal: The Journal of dermatological treatment

Published: November 12, 2025

Topical propranolol for infantile hemangioma: a comprehensive review of mechanisms, clinical efficacy, and novel formulations.

Journal: Frontiers in pediatrics

Published: November 11, 2025

Vascular Birthmark Latest Advances

Find the Latest Research About Vascular Birthmark

Bridging the Gap: Infantile Hemangioma Care Variability Among Pediatric Care Physicians in Greece.

Bridging the Gap: Infantile Hemangioma Care Variability Among Pediatric Care Physicians in Greece.

A calf with concurrent infantile hemangioma and coronary artery fistula: notes on simultaneous onset.

A calf with concurrent infantile hemangioma and coronary artery fistula: notes on simultaneous onset.

Early Infantile Hemangioma Diagnosis Is Key in Skin of Color.

Early Infantile Hemangioma Diagnosis Is Key in Skin of Color.

Soft tissue atrophy following intralesional corticosteroid injection for infantile hemangioma: A retrospective cohort study.

Soft tissue atrophy following intralesional corticosteroid injection for infantile hemangioma: A retrospective cohort study.

Risk Factors for Airway Infantile Hemangioma.

Risk Factors for Airway Infantile Hemangioma.

A Systematic Review and Meta-Analysis of the Efficacy and Safety of Propranolol Versus Other Drugs in the Treatment of Infantile Hemangioma.

A Systematic Review and Meta-Analysis of the Efficacy and Safety of Propranolol Versus Other Drugs in the Treatment of Infantile Hemangioma.

Discussion: Long-Term Outcomes of Oral Propranolol for Facial Infantile Hemangioma.

Discussion: Long-Term Outcomes of Oral Propranolol for Facial Infantile Hemangioma.

Artificial intelligence for diagnosis and treatment recommendation in infantile hemangioma: A retrospective multicenter diagnostic accuracy study.

Artificial intelligence for diagnosis and treatment recommendation in infantile hemangioma: A retrospective multicenter diagnostic accuracy study.

Clinical Management and Genetic Analysis of a Complex Case of Segmental Infantile Hemangioma with Subcutaneous Pelvic and Gluteal Tumefactions.

Clinical Management and Genetic Analysis of a Complex Case of Segmental Infantile Hemangioma with Subcutaneous Pelvic and Gluteal Tumefactions.

RETRACTION: Our Experience With Propranolol for Infantile Hemangioma.

RETRACTION: Our Experience With Propranolol for Infantile Hemangioma.

Clinical characteristics, treatment outcomes and prognostic factors of ulcerated infantile hemangioma: 15 years of experience from a pediatric dermatology center in Hong Kong.

Clinical characteristics, treatment outcomes and prognostic factors of ulcerated infantile hemangioma: 15 years of experience from a pediatric dermatology center in Hong Kong.

Topical propranolol for infantile hemangioma: a comprehensive review of mechanisms, clinical efficacy, and novel formulations.

Topical propranolol for infantile hemangioma: a comprehensive review of mechanisms, clinical efficacy, and novel formulations.